Insulet
PODD
#1051
Rank
C$25.69 B
Marketcap
$366.25
Share price
-0.40%
Change (1 day)
52.39%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.32

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.42. In 2022 the company made an earnings per share (EPS) of $0.09856 a decrease over its 2021 EPS that were of $0.32.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.322255.35%
2022$0.09856-69.57%
2021$0.32109.09%
2020$0.15-38.89%
2019$0.25200%
2018$0.08448-113.04%
2017-$0.65-9.8%
2016-$0.72-60.77%
2015-$1.8339.78%
2014-$1.3112.05%
2013-$1.17-23.15%
2012-$1.5210.2%
2011-$1.38-36.36%
2010-$2.17-36.63%
2009-$3.42-29.36%
2008-$4.84-86.74%
2007-$36.53-64.04%
2006-$101.59122.23%
2005-$45.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.84-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.55-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.38-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.83 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.18 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.83 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$7.64 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA